Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Kevin Boyle Sr Net Worth & Insider Trades

Kevin Boyle Sr - Chief Executive Officer, Ziopharm Oncology Inc

As of November 17, 2021

What is Kevin Boyle Sr's Net Worth?

The current estimated net worth of Ziopharm Oncology Inc's Chief Executive Officer, Kevin Boyle Sr, is estimated to be about $9.54K . Kevin Boyle Sr owns about 885,000 units of Ziopharm Oncology Inc common stock. In the last 3 months at Ziopharm Oncology Inc, Kevin Boyle Sr has sold an estimated value of $0 worth.

What is Kevin Boyle Sr's Past Insider Trading?

Kevin Boyle Sr's largest purchase order was 10,000 units , worth over $14K on November 17, 2021. In total, Kevin Boyle Sr has made about 2 transactions over 3 months of their time at Ziopharm Oncology Inc. Kevin Boyle Sr usually trades in November and August, with the busiest year in 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kevin Boyle Sr

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Kevin Boyle Sr's' Mailing Address?

  • Mailing address is C/o Ziopharm Oncology, Inc. One First Avenue, Parris Bldg 34 Boston MA 02129 MA

What are Ziopharm Oncology Inc's Past Insider Trades?

Ziopharm Oncology Inc's most recent insider trade came on December 27, 2021 by Eleanor de Groot who sold 20,132 units worth $25.57K . In the last 14 years, insiders at Ziopharm Oncology Inc have sold an estimated value of $13.56M and bought an estimated value of $76.75M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Randal Kirk, Director,  Intrexon Corp,  and Anthony James Cannon, Director .

ZIOPHARM ONCOLOGY INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...